COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine

Cui, 2019, Origin and evolution of pathogenic coronaviruses, Nat. Rev. Microbiol., 17, 181, 10.1038/s41579-018-0118-9 Su, 2016, Epidemiology, genetic recombination, and pathogenesis of coronaviruses, Trends Microbiol., 24, 490, 10.1016/j.tim.2016.03.003 https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Saeedi, 2019, Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition, Diabetes Res. Clin. Pract., 157, 10.1016/j.diabres.2019.107843 Sayed, 2020, Diabetes and genetics: a relationship between genetic risk alleles, clinical phenotypes and therapeutic approaches, Adv. Exp. Med. Biol., 10.1007/5584_2020_518 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 382, 1708, 10.1056/NEJMoa2002032 Onder, 2020, Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy [published online ahead of print, 2020 Mar 23], JAMA Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention, JAMA, 10.1001/jama.2020.2648 Bode, 2020, Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. [published online ahead of print, 2020 May 9], J. Diabetes Sci. Technol. Yan, 2020, Clinical characteristics and outcomes of patients with severe covid-19 with diabetes, BMJ Open Diabetes Res. Care, 8, 10.1136/bmjdrc-2020-001343 Andersen, 2020, The proximal origin of SARS-CoV-2, Nat. Med., 10.1038/s41591-020-0820-9 Guan, 2020, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur. Respir. J., 10.1183/13993003.00547-2020 Van-Laethem, 2020, Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019. [published online ahead of print, 2020 Apr 30], J. Intern. Med. Nikpouraghdam, 2020, Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: a single Center Study. [published online ahead of print, 2020 Apr 21], J. Clin. Virol., 127 Gold, 2020, Characteristics and clinical outcomes of adult patients hospitalized with COVID-19- Georgia, March 2020, MMER Morb Mortal Wkly Rep, 69, 545, 10.15585/mmwr.mm6918e1 Itelman, 2020, Clinical characterization of 162 COVID-19 patients in Israel: preliminary report from a large tertiary center, Isr. Med. Assoc. J., 22, 271 Barron, 2020 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Walls, 2020, Veesler D Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 10.1016/j.cell.2020.11.032 Liu, 2020, ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection [published online ahead of print, 2020 Apr 22], Clin. Gastroenterol. Hepatol. Lukassen, 2020, SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J., 39, 10.15252/embj.20105114 Zou, 2020, Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front. Med., 14, 185, 10.1007/s11684-020-0754-0 Muniyappa, 2020, COVID-19 pandemic, coronaviruses, and diabetes mellitus, Am. J. Physiol. Endocrinol. Metab., 318, E736, 10.1152/ajpendo.00124.2020 de Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat. Rev. Microbiol., 14, 523, 10.1038/nrmicro.2016.81 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir. Med., 8, 475, 10.1016/S2213-2600(20)30079-5 Zhang, 2020, Clinical characteristics of 140 patients infected with SARS CoV-2 in Wuhan, China.[published online ahead of print, 2020 Feb 19], Allergy Palm, 2007, Not so fast: adaptive suppression of innate immunity, Nat. Med., 13, 1142, 10.1038/nm1007-1142b Gao, 2020, Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. [published online ahead of print, 2020 Mar 17], J. Med. Virol. Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0 Wan, 2020, Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) (Preprint), medRxiv Diao, 2020, Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19, Front. Immunol., 10.3389/fimmu.2020.00827 Alexandraki, 2006, Inflammatory process in type 2 diabetes: the role of cytokines, Ann. N. Y. Acad. Sci., 1084, 89, 10.1196/annals.1372.039 Rao, 2020, Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019nCov: a Mendelian randomization analysis (Preprint), Diabetes Care, 10.2337/dc20-0643 Fernandez, 2018, Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality, J. Intern. Med., 284, 377, 10.1111/joim.12783 Ribeiro-Oliveira, 2008, The renin-angiotensin system and diabetes: an update, Vasc. Health Risk Manag., 4, 787 Nehme, 2019, An update on the tissue renin angiotensin system and its role in physiology and pathology, J. Cardiovasc. Dev. Dis., 6, 14, 10.3390/jcdd6020014 Lelis, 2019, Angiotensin-(1-7), Adipokines and inflammation, Metabolism, 95, 36, 10.1016/j.metabol.2019.03.006 Cure, 2020, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic [published online ahead of print, 2020 Apr 15], Diabetes Metab. Syndr., 14, 349, 10.1016/j.dsx.2020.04.019 Cure, 2020, Comment on "Organ-protective effect of angiotensin converting enzyme 2 and its effect on the prognosis of COVID-19, J. Med. Virol., 10.1002/jmv.25848 Tipnis, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J. Biol. Chem., 275, 10.1074/jbc.M002615200 Patel, 2012, Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes, Am. J. Hypertens., 25, 216, 10.1038/ajh.2011.188 Liu, 2018, ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus, Cardiovasc. Diabetol., 17, 127, 10.1186/s12933-018-0771-3 Pan, 2018, Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China, Lipids Health Dis., 17, 241, 10.1186/s12944-018-0890-6 Luo, 2019, Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang, Hypertens. Res., 42, 681, 10.1038/s41440-018-0166-6 Chaoxin, 2013, The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease, Eur. Rev. Med. Pharmacol. Sci., 17, 2654 Li, 2005, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309, 1864, 10.1126/science.1116480 Li, 2005, Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2, EMBO J., 24, 1634, 10.1038/sj.emboj.7600640 Procko, 2020, The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2, bioRxiv : the preprint server for biology, 2020 Darbani, 2020, The expression and polymorphism of entry machinery for COVID-19 in human: juxtaposing population groups, gender, and different tissues, Int. J. Environ. Res. Public Health, 17, E3433, 10.3390/ijerph17103433 Hussain, 2020, Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein, J. Med. Virol., 10.1002/jmv.25832 Othman, 2020, Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism [published online ahead of print, 2020 May 14], Biochem. Biophys. Res. Commun., 10.1016/j.bbrc.2020.05.028 Marmor, 2006, Resistance to HIV infection, J. Urban Health, 83, 5, 10.1007/s11524-005-9003-8 Oyugi, 2009, A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers, J. Infect. Dis., 199, 1327, 10.1086/597616 Strollo, 2020, DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? [published online ahead of print, 2020 Apr 26], Diabetes Metab. Res. Rev. Raj, 2013, Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC, Nature, 495, 251, 10.1038/nature12005 Iacobellis, 2020, COVID-19 and diabetes: can DPP4 inhibition play a role?, Diabetes Res. Clin. Pract., 162, 10.1016/j.diabres.2020.108125 Vankadari, 2020, Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerg. Microbes Infect., 9, 601, 10.1080/22221751.2020.1739565 Wang, 2014, Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26, Cell Host Microbe, 16, 328, 10.1016/j.chom.2014.08.009 Kleine-Weber, 2020, Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus, Emerg. Microbes Infect., 9, 155, 10.1080/22221751.2020.1713705 Atkinson, 2014, Type 1 diabetes, Lancet, 383, 69, 10.1016/S0140-6736(13)60591-7 Op de Beeck A, 2016, Viral infections in type 1 diabetes mellitus–why the b cells?, Nat. Rev. Endocrinol., 12, 263, 10.1038/nrendo.2016.30 Lönnrot, 2017, Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study, Diabetologia, 60, 1931, 10.1007/s00125-017-4365-5 Ruiz, 2018, Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study, Diabetologia, 61, 1996, 10.1007/s00125-018-4662-7 Cariou B., Hadjadj S., Wargny M., Pichelin M., Al-Salameh A., Allix I. et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. In press. Epub ahead of print. doi:10.1007/s00125-020- 05180-x. https://www.medscape.com/viewarticle/927567?nlid=134689_3044&src=WNL_ mdplsnews_200327_mscpedit_diab&uac=75759MY&spon=22&impID=2326416& faf=1. Tatti, 2020, Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19?, Med. Hypotheses, 10.1016/j.mehy.2020.109795 Telemedicine-Opportunities and developments in member states [Internet].second ed. Geneva, Switzerland: WHO press; 2010 Available from:https://www.who.int/goe/publications/goe_telemedicine_2010.pd]. Ghosh, 2020, Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians [published online ahead of print, 2020 Apr 4], Diabetes Metab. Syndr., 14, 273, 10.1016/j.dsx.2020.04.001 Zhai, 2014, Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis, Bull. Sch. Med. Md, 93, e312 Gopalan, 2019, Diabetes care at doorsteps": a customised mobile van for the prevention, screening, detection and management of diabetes in the urban underprivileged populations of Delhi, Diabete Metab., 13 Bonora, 2020, Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 Outbreak in Italy [published online ahead of print, 2020 may 11], Diabetes Ther., 1 Fernández, 2020, Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes, Diabetes Res. Clin. Pract. Suppl., 10.1016/j.diabres.2020.108348 Peters, 2020, The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth [published online ahead of print, 2020 May 5], Diabetes Technol. Ther. Nørgaard K. Telemedicine Consultations and Diabetes Technology During COVID-19 [published online ahead of print, 2020 May 19]. J Diabetes Sci Technol. 2020;1932296820929378. doi:10.1177/1932296820929378.